Work

Prospective Phase II Trial of Cemiplimab Plus Gemcitabine in SWItch/Sucrose Nonfermentable-Altered Metastatic Pancreatic Ductal Adenocarcinoma

Year: 2026

Type: article

Source: JCO oncology advances.

DOI: 10.1200/oa-26-00074

Authors: Shawn A. Abeynaike, Roberta Vezza Alexander, Christina A. Snider, In Hwan Park, Shumei Kato, Razelle Kurzrock, Diana C. Hargreaves, Karen S. Messer, Gregory P. Botta

Institutions: University of California San Diego, Moores Cancer Center, Medical College of Wisconsin, Salk Institute for Biological Studies

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W7203763762

FWCI:

Cites: 8

Cited by:

Related to: